PMID: 9160068May 1, 1997Paper

Systemic radionuclide therapy with strontium chloride Sr 89 for painful skeletal metastases in prostate and breast cancer

Southern Medical Journal
B R Patel, W M Flowers

Abstract

Systemic radionuclide therapy with strontium chloride Sr 89 is a rediscovered alternative to relieve pain from bony metastases. Although numerous advances have been made in the diagnosis and treatment of cancer, pain remains a serious and debilitating disease complication. An increasing number of clinical trials are reporting satisfactory results with 89Sr-chloride therapy, now available for widespread clinical use. We have treated 11 patients with this radionuclide; of these patients, 8 had excellent to dramatic pain relief and 3 had mild to moderate improvement. Clinical response was based on subjective pain relief, increased mobility, decreased analgesic uptake, and/or improvement in daily activities, including work habits.

Citations

Mar 13, 2002·Drugs & Aging·R C PelgerN A Hamdy
Mar 23, 2011·The Surgical Clinics of North America·Jennifer N WuChristopher P Evans
Sep 8, 2005·The Journal of Urology·Joon-Ha OkChristopher P Evans
Apr 19, 2005·Hematology/oncology Clinics of North America·Michelle Boyar, Harry Raftopoulos
Dec 14, 2011·Annals of Nuclear Medicine·Isao Kuroda

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Related Papers

The American Journal of Hospice & Palliative Care
Howard SmithScott M Fishman
The New England Journal of Medicine
N A Christakis, J J Escarce
Current Opinion in Pulmonary Medicine
Andrew L ChanTimothy E Albertson
© 2021 Meta ULC. All rights reserved